GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (NYSE:GSK) » Definitions » FCF Margin %

GSK (GSK) FCF Margin %

: 29.97% (As of Dec. 2023)
View and export this data going back to 1987. Start your Free Trial

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. GSK's Free Cash Flow for the three months ended in Dec. 2023 was $3,054 Mil. GSK's Revenue for the three months ended in Dec. 2023 was $10,192 Mil. Therefore, GSK's FCF Margin % for the quarter that ended in Dec. 2023 was 29.97%.

As of today, GSK's current FCF Yield % is 6.84%.

The historical rank and industry rank for GSK's FCF Margin % or its related term are showing as below:

GSK' s FCF Margin % Range Over the Past 10 Years
Min: 2.79   Med: 16.49   Max: 26.67
Current: 14.76


During the past 13 years, the highest FCF Margin % of GSK was 26.67%. The lowest was 2.79%. And the median was 16.49%.

GSK's FCF Margin % is ranked better than
83.79% of 1024 companies
in the Drug Manufacturers industry
Industry Median: -0.68 vs GSK: 14.76


GSK FCF Margin % Historical Data

The historical data trend for GSK's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.35 26.67 21.45 17.55 14.59

GSK Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.65 -6.85 10.76 21.05 29.97

Competitive Comparison

For the Drug Manufacturers - General subindustry, GSK's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK FCF Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, GSK's FCF Margin % distribution charts can be found below:

* The bar in red indicates where GSK's FCF Margin % falls into.



GSK FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

GSK's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=5600/38389.873
=14.59 %

GSK's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=3054.431/10192.405
=29.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GSK FCF Margin % Related Terms

Thank you for viewing the detailed overview of GSK's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK (GSK) Business Description

Address
980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS
In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.